title: Erratum to: Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.
authors: Mount Sinai Heart, Cardiometabolics Unit, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, MC1 Level, New York, NY, 10029, USA. robert.rosenson@mssm.edu.
authors: Robert S
authors: RS
authors: Rosenson
authors: Emory University, 201 Dowman Drive, Atlanta, GA, 30322, USA.
authors: Terry A
authors: TA
authors: Jacobson
authors: Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford University, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LF, UK.
authors: David
authors: D
authors: Preiss
authors: Amgen Inc., One Amgen Center Dr, Thousand Oaks, CA, 91320, USA.
authors: Stephen C
authors: SC
authors: Djedjos
authors: Amgen (Europe) GmbH, Dammstrasse 23, 6300, Zug, Switzerland.
authors: Ricardo
authors: R
authors: Dent
authors: Amgen Ltd, 240 Cambridge Science Park, Milton, Cambridge, CB4 0WD, UK.
authors: Ian
authors: I
authors: Bridges
authors: University of Maryland School of Medicine, 655 W Baltimore St, Baltimore, MD, 21201, USA.
authors: Michael
authors: M
authors: Miller